Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix to Use TriLink Oligos in Kits

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix will use TriLink Biotechnologies' oligonucleotides in several of its kits under an agreement announced today by the firms.

The partners did not disclose terms of the agreement, but said it is a multi-year distribution and supply pact. They also did not specify which Affy kits would contain the oligos.

San Diego-based TriLink makes custom oligos, modified nucleoside triphosphates and CleanAmp PCR products for the diagnostics and OEM markets.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.